FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4239046640> ?p ?o ?g. }

• W4239046640 endingPage "661" @default.
• W4239046640 startingPage "652" @default.
• W4239046640 abstract "Objective: Lithium remains the cornerstone of maintenance therapy for bipolar disorder despite growing use of other agents, including divalproex, lamotrigine, carbamazepine and the atypical antipsychotics. Lithium has the largest body of data to support its continued use as a prophylactic agent; however, most of this data comes from early studies that did not use contemporary analytic methods. Alternatives to lithium are needed because of the relatively high rate of non-response to lithium monotherapy and the drug's frequent side-effects. This article reviews available data with an emphasis on double-blind, placebo controlled studies that examine the efficacy of lithium and other putative mood stabilizers: carbamazepine, divalproex, lamotrigine and olanzapine.Method: The authors reviewed key literature using Medline searches using key words: bipolar disorder, controlled trials, mood stabilizer, lithium, lomotrigine, divalproex, olanzapine, carbamazepine.Results: Lithium remains the gold standard for overall preventative efficacy in bipolar disorder, especially to decrease manic or hypomanic relapse. Of the mood stabilizers that have marked prophylactic antimanic properties, lithium appears to possess the greatest antidepressant effect. Divalproexmay also prevent recurrent bipolar mood episodes but the relative lack of controlled maintenance studies makes this less certain. There now exists an extensive and well-designed research database supporting the use of lamotrigine in the acute and prophylactic management of bipolar I disorder. Lamotrigine offers a spectrum of clinical effectiveness that complements lithium, in that it appears to stabilize mood ‘from below baseline’ by preventing episodes of depression and has been shown to be effective in rapid-cycling bipolar II disorder. Carbamazepine may be a useful alternative to lithium, divalproex and lamotrigine, particularly for patients with a history of mood-incongruent delusions and other comorbidities, but controlled data is more equivocal and it may lose some of its prophylactic effect over time. Emerging data continue to support the growing use of atypical antipsychotics, particularly olanzapine.Conclusions: Any monotherapy for use as a maintenance therapy of bipolar disorder appears to be inadequate for long-term use in the management of the majority of patients with bipolar disorder. Combination therapy has become the standard of care in the treatment of bipolar disorder and particularly in patients with treatment-refractory variants such as those with rapid-cycling. The emerging consensus is that patients on monotherapy, if followed for sufficiently long periods, will eventually require concomitant treatment to maintain a full remission. There exists a need for controlled trials that use random assignment to parallel arms including combination therapy followed by data analyses that include both relapse rate and survival techniques." @default.
• W4239046640 created "2022-05-12" @default.
• W4239046640 creator A5039228625 @default.
• W4239046640 creator A5072873693 @default.
• W4239046640 date "2005-08-01" @default.
• W4239046640 modified "2023-10-14" @default.
• W4239046640 title "Maintenance therapies in bipolar disorder: focus on randomized controlled trials" @default.
• W4239046640 cites W1990011346 @default.
• W4239046640 cites W1991621530 @default.
• W4239046640 cites W1992377978 @default.
• W4239046640 cites W1994161727 @default.
• W4239046640 cites W2010520341 @default.
• W4239046640 cites W2016035794 @default.
• W4239046640 cites W2019823288 @default.
• W4239046640 cites W2022794409 @default.
• W4239046640 cites W2025609587 @default.
• W4239046640 cites W2028464981 @default.
• W4239046640 cites W2035130364 @default.
• W4239046640 cites W2039273279 @default.
• W4239046640 cites W2041989812 @default.
• W4239046640 cites W2046115542 @default.
• W4239046640 cites W2051806956 @default.
• W4239046640 cites W2058120764 @default.
• W4239046640 cites W2058662910 @default.
• W4239046640 cites W2061070907 @default.
• W4239046640 cites W2064119388 @default.
• W4239046640 cites W2072655433 @default.
• W4239046640 cites W2084399232 @default.
• W4239046640 cites W2091567758 @default.
• W4239046640 cites W2093576586 @default.
• W4239046640 cites W2099824577 @default.
• W4239046640 cites W2105603256 @default.
• W4239046640 cites W2118434940 @default.
• W4239046640 cites W2121339106 @default.
• W4239046640 cites W2130040176 @default.
• W4239046640 cites W2130261986 @default.
• W4239046640 cites W2136125265 @default.
• W4239046640 cites W2141895871 @default.
• W4239046640 cites W2147420992 @default.
• W4239046640 cites W2155066293 @default.
• W4239046640 cites W2162376922 @default.
• W4239046640 cites W2338664084 @default.
• W4239046640 cites W4247269873 @default.
• W4239046640 doi "https://doi.org/10.1111/j.1440-1614.2005.01649.x" @default.
• W4239046640 hasPublicationYear "2005" @default.
• W4239046640 type Work @default.
• W4239046640 citedByCount "10" @default.
• W4239046640 countsByYear W42390466402012 @default.
• W4239046640 countsByYear W42390466402015 @default.
• W4239046640 countsByYear W42390466402019 @default.
• W4239046640 countsByYear W42390466402021 @default.
• W4239046640 crossrefType "journal-article" @default.
• W4239046640 hasAuthorship W4239046640A5039228625 @default.
• W4239046640 hasAuthorship W4239046640A5072873693 @default.
• W4239046640 hasConcept C118552586 @default.
• W4239046640 hasConcept C126322002 @default.
• W4239046640 hasConcept C15744967 @default.
• W4239046640 hasConcept C168563851 @default.
• W4239046640 hasConcept C2775858608 @default.
• W4239046640 hasConcept C2776174506 @default.
• W4239046640 hasConcept C2776412080 @default.
• W4239046640 hasConcept C2776592573 @default.
• W4239046640 hasConcept C2776619155 @default.
• W4239046640 hasConcept C2776809841 @default.
• W4239046640 hasConcept C2778186239 @default.
• W4239046640 hasConcept C2778541603 @default.
• W4239046640 hasConcept C2778802184 @default.
• W4239046640 hasConcept C2779253243 @default.
• W4239046640 hasConcept C2780550438 @default.
• W4239046640 hasConcept C2780733359 @default.
• W4239046640 hasConcept C2781246090 @default.
• W4239046640 hasConcept C2908949014 @default.
• W4239046640 hasConcept C71924100 @default.
• W4239046640 hasConceptScore W4239046640C118552586 @default.
• W4239046640 hasConceptScore W4239046640C126322002 @default.
• W4239046640 hasConceptScore W4239046640C15744967 @default.
• W4239046640 hasConceptScore W4239046640C168563851 @default.
• W4239046640 hasConceptScore W4239046640C2775858608 @default.
• W4239046640 hasConceptScore W4239046640C2776174506 @default.
• W4239046640 hasConceptScore W4239046640C2776412080 @default.
• W4239046640 hasConceptScore W4239046640C2776592573 @default.
• W4239046640 hasConceptScore W4239046640C2776619155 @default.
• W4239046640 hasConceptScore W4239046640C2776809841 @default.
• W4239046640 hasConceptScore W4239046640C2778186239 @default.
• W4239046640 hasConceptScore W4239046640C2778541603 @default.
• W4239046640 hasConceptScore W4239046640C2778802184 @default.
• W4239046640 hasConceptScore W4239046640C2779253243 @default.
• W4239046640 hasConceptScore W4239046640C2780550438 @default.
• W4239046640 hasConceptScore W4239046640C2780733359 @default.
• W4239046640 hasConceptScore W4239046640C2781246090 @default.
• W4239046640 hasConceptScore W4239046640C2908949014 @default.
• W4239046640 hasConceptScore W4239046640C71924100 @default.
• W4239046640 hasIssue "8" @default.
• W4239046640 hasLocation W42390466401 @default.
• W4239046640 hasOpenAccess W4239046640 @default.
• W4239046640 hasPrimaryLocation W42390466401 @default.
• W4239046640 hasRelatedWork W1806022048 @default.
• W4239046640 hasRelatedWork W2030567557 @default.

• next